Share chart Arcellx, Inc.
Extended chart
Simple chart
About Arcellx, Inc.
Arcellx, Inc., биотехнологическая компания клинической стадии, занимается разработкой различных иммунотерапевтических средств для пациентов с раком и другими неизлечимыми заболеваниями. Ведущим кандидатом продукта ddCAR компании является CART-ddBCMA, который находится в фазе 1 клинических испытаний для лечения пациентов с рецидивирующей или рефрактерной (r/r) множественной миеломой (ММ). more details| IPO date | 2022-02-04 |
|---|---|
| ISIN | US03940C1009 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | https://arcellx.com |
| Цена ао | 70.11 |
| Change price per day: | 0% (59.15) |
|---|---|
| Change price per week: | +4.41% (56.65) |
| Change price per month: | -17.37% (71.58) |
| Change price per 3 month: | -12.19% (67.36) |
| Change price per half year: | -34.21% (89.91) |
| Change price per year: | +3.84% (56.96) |
| Change price per 3 year: | +369.44% (12.6) |
| Change price per year to date: | -21.58% (75.43) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Perceptive Advisors LLC | 4544809 | 8.61 |
| FMR, LLC | 4379169 | 8.29 |
| NEA Management Company, LLC | 3745262 | 7.09 |
| Paradigm Biocapital Advisors LP | 3658624 | 6.93 |
| SR One Capital Management, LP | 3146630 | 5.96 |
| Blackrock Inc. | 3018538 | 5.72 |
| Suvretta Capital Management, LLC | 2435974 | 4.61 |
| Vanguard Group Inc | 2061819 | 3.91 |
| State Street Corporation | 1773839 | 3.36 |
| Cormorant Asset Management, LP | 1700000 | 3.22 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| Future Tech ETF | 0.44959 | 426.34 | 0.8416 |
| Principal Healthcare Innovators ETF | 0.44959 | 618.5 | 0.8416 |
| iShares Morningstar Small-Cap ETF | 0.07388 | 391.25 | 1.60498 |
| 0.32 | 478.7 | 1.09 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Rami Elghandour | Chairman of the Board, CEO & President | 1.02M | 1979 (46 years) |
| Mr. Neeraj P. Teotia | Chief Commercial Officer | 461.95k | 1975 (50 years) |
| Dr. Christopher R. Heery M.D. | Chief Medical Officer | 688.55k | 1980 (45 years) |
| Ms. Michelle Lim Gilson | Chief Financial Officer | 832.8k | 1993 (32 years) |
| Mr. Narinderjeet Singh M.S. | Chief Technical Officer | N/A | 1972 (53 years) |
| Mr. David Tice Ph.D. | Chief Scientific Officer | N/A | 1971 (54 years) |
| Ms. Myesha Lacy | Chief Investor & Communications Officer | N/A | |
| Ms. Maryam Abdul-Kareem J.D., M.S. | General Counsel & Chief Legal Officer | N/A | |
| Ms. Kate Aiken | Chief People Officer | N/A | |
| Ms. Aileen Fernandes | Chief Business Officer | N/A |
Address: United States, Gaithersburg. MD, 25 West Watkins Mill Road - open in Google maps, open in Yandex maps
Website: https://arcellx.com
Website: https://arcellx.com
